March 16, 2017
Stada confirms postponing Board bidding session
Stada’s Supervisory Board has postponed expert sessions which were planned as part of the structured bidding process.
Pharmaceuticals, Biotechnology and Life Sciences
Category: Regions
March 16, 2017
Cannabis industry turning into multi-billion dollar opportunity
In the United States, this market’s massive growth potential is being recognized as new states legalize marijuana for medical or recreational use. Industry experts forecast the U.S. cannabis market rounding $7 billion in 2016, while the annual sale of state-legal cannabis products is forecast to exceed $20 billion by 2020.
March 16, 2017
Bone Therapeutics reports €13 million net loss for 2016
Bone Therapeutics, the bone cell therapy company, has reported net loss of €13,02 million for 2016 which is slight decrease in loss comaring to last years €14,07 million net loss.
March 16, 2017
Shire gets European approval for Llabel extension of Cinryze
Shire said on Thursday that the European Commission (EC) has approved a label extension granting three new indications for CINRYZE® (C1 inhibitor [human]), broadening its use to children with Hereditary angiodema (HAE), a rare, genetic disorder that results in recurring attacks of edema (swelling). The body sites most commonly affected are mainly the extremities and abdomen.
March 16, 2017
USPTO favorable to Ceylad
The U.S. Patent and Trademark Office (USPTO) has been favorable to Ceylad for the fourth time for production of Allogenic TCR-Deficient CAR-T cells.
March 16, 2017
CPhI Japan 2017 PIC/S membership accelerating international interest with market forecast to reach US$115bn by 2024
An ageing population, a growing generics market and liberalization of Over-The-Counter medicines make Japan an attractive destination for investments, particularly as the pharma industry undergoes legislative change, with the Government’s bid to cut healthcare expenditure.
March 16, 2017
Cresco’s subsidiary gets approval in Czech Republic for one of its products
Creso Pharma’s subsidiary HempIndustries s.r.o. (HI) has received regulatory approval in the Czech Republic to sell its new product line called diCBDIUM.
The approval by the Czech Ministry of Agriculture, means that HI can …
March 16, 2017
Millenium Dental Technologies reached FDA clearance for True Regeneration milestone
Millennium Dental Technologies, Inc. has reached milestone today in the one-year anniversary of the world’s first and only US FDA clearance for full-mouth True Periodontal Regeneration.
March 15, 2017
Severe asthma market is driving Nucala sales, opportunity for Teva, AstraZeneca, Sanofi, and Regeneron
Decision Resources Group (DRG) finds that Nucala’s novel mechanism of action and specific indication for eosinophilic asthma are key drivers behind the agent’s recent success in the severe asthma market.
March 15, 2017
Envigo reacts on growth in the use of non-animal technologies in pharmaceutical and chemical safety assessment
Envigo announced on Wednesday that it will develop and internally validate five to seven ion channel In vitro tests for measuring cardiac risk potential